Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) is currently indicated for
the treatment of failed surgical tissue valves in patients determined to be at high surgical risk …

Introduction Valve-in-valve (VIV) transcatheter valve replacement has emerged as a feasible
and potentially safer treatment option for failed bioprosthetic surgical valves (BSVs) …

Background Bioprosthetic valve fracture (BVF) can be used to improve transcatheter heart
valve (THV) haemodynamics following a valve-in-valve (ViV) intervention. However, whether …

Aortic valve-in-valve (ViV) procedures are increasingly performed for the treatment of
surgical bioprosthetic valve failure in patients at intermediate to high surgical risk. Although …

Objectives To determine the outcomes of bioprosthetic valve fracture (BVF) in valve‐in‐valve
transcatheter aortic valve implantation (ViV‐TAVI) for patients with structural valve …

Transcatheter aortic valve-in-valve replacement presents a viable, minimally invasive
approach to replacing degraded bioprosthetic surgical valves. The major drawback of this …

Objectives The aim of this study was to investigate the degree of functional improvement of a
transcatheter heart valve (THV) for valve‐in‐valve after bioprosthetic valve fracture (BVF) of …

Background Transcatheter aortic valve implantation (TAVI) is associated with new onset
brady-and tachyarrhythmias which may impact clinical outcome. Aims To investigate the true …

While redo surgical aortic valve replacement has traditionally been the gold standard for the
treatment of failed surgical valves, valve-in-valve (ViV) transcatheter aortic valve …

Background Bioprosthetic valve fracturing (BVF) results in low gradients following valve-in-
valve transcatheter aortic valve replacement (ViV-TAVR). For the commonly used Edwards …